pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
934
stories
May 1, 26
Arvinas’ ‘Protac’ breast cancer drug cleared by FDA
biopharma dive
May 1, 26
FDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming data
endpoints
May 1, 26
Summit’s ‘self-inflicted’ stumble; Esperion’s take-private deal
biopharma dive
May 1, 26
Moderna sees revenue bump from international COVID vaccine sales
biopharma dive
May 1, 26
Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook
biopharma dive
May 1, 26
PFAS is still in some infant formula
stat
May 1, 26
Summit slips on ivonescimab's apparent interim miss in sign of investor frustration
endpoints
May 1, 26
‘Forever chemicals’ in baby formula? Scientists unpack FDA results
stat
May 1, 26
Two biotechs raise a combined $556M in latest spurt of IPOs
biopharma dive
Apr 30, 26
Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstood
stat
Apr 30, 26
STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHA
stat
Apr 30, 26
STAT+: Hair-raising trial results, and Servier’s M&A wishlist
stat
Apr 30, 26
FDA's oncology advisors vote against 'new paradigm' in AstraZeneca trial
endpoints
Apr 30, 26
Krazati fails confirmatory trial in colorectal cancer, putting approval at risk
endpoints
Apr 30, 26
Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole Saphier
stat
Apr 30, 26
Merck still sees ‘compelling’ outlook for Terns leukemia drug
biopharma dive
Apr 30, 26
STAT+: Hinge has a new FDA-cleared migraine device
stat
Apr 30, 26
STAT+: What does Akeso’s primo plenary spot say about its survival data?
stat
Apr 30, 26
Securing NIH awards is getting more competitive — and confusing
stat
Apr 30, 26
Avalyn, in pursuit of better lung drugs, banks $300M in an IPO
biopharma dive
Apr 29, 26
FDA, AstraZeneca prep for oncology adcomm
endpoints
Apr 29, 26
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
biopharma dive
Apr 29, 26
STAT+: A patent win for Pfizer and BridgeBio
stat
Apr 29, 26
New report shows some health equity wins. Experts fear they will be short-lived
stat
Apr 28, 26
STAT+: Health system CEOs get off easy at Congressional hearing on affordability
stat
Apr 28, 26
STAT+: FDA launches effort to speed up clinical trials, using AI
stat
Apr 28, 26
Opinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug development
stat
Apr 28, 26
Fauci adviser David Morens indicted on charges of concealing emails, avoiding records requests
stat
Apr 28, 26
BeOne Medicines licenses trispecific antibody targeting PD-1, CTLA-4 and VEGF
endpoints
Apr 28, 26
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results
biopharma dive
← prev
page 30 of 32
next →
